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ABSTRACT 
Diabetes mellitus is a major health problem in the world. There is no cure for diabetes. It is, therefore, essential to practice effective methods of the 
diagnosis, treatment, and management of diabetes. With the increase in a number of newer drugs for diabetes, there is the possibility of a wide 
range of side effects that vary from one drug to another. Hence, the need to explore oral antidiabetic drugs of natural origin with minimal side 
effects is highly essential. This review provides a scientific perspective on the usage and research of natural and Indian traditional remedies in the 
management of diabetes while also providing insight into the advances in our understanding of diabetic pathology.  
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INTRODUCTION 
DM (Diabetes mellitus) is one of the leading health problems in the 
world. More than 366 million people are affected with this metabolic 
disorder, and the projected prevalence is estimated to be 522 
million by 2030 [1]. The burden of DM is high in developed and 
developing countries. DM now affects 7 % of the world’s adult 
population. Data from the literature suggests that 8.3 % of the total 
population of the United States has diabetes, and 79 million adults 
have pre-diabetes [2]. The content of this review has been taken 
from various journal archiving services such as PubMed, Science 
Direct, Springer, and Scopus. The search criteria were limited to 
recent research in natural products for the management of DM.  
Types of diabetes 
DM is caused to the defects in insulin secretion, insulin action or 
both. Insulin deficiency, in turn, leads to chronic hyperglycemia 
(very high blood glucose levels) with disturbances in carbohydrate, 
fat and protein metabolism. Insulin dependent (IDDM) is type-1 DM 
and Non-Insulin dependent (NIDDM) is type-2 DM. DM in humans is 
a result of metabolic disturbances due to the dietary intake of excess 
carbohydrate and lipid [3]. Type-1 diabetes is most likely to occur in 
relatives of affected persons. It is associated with the autoimmune 
destruction of pancreatic β which leads to complete deficiency of 
insulin secretion [4]. Type-2 diabetes is a chronic and progressive 
syndrome, caused by the combination of resistance to insulin action 
and impaired insulin secretion. This results in more than 90 % of 
cases [5]. Glucose homeostasis is maintained by the liver, which also 
accumulates hepatic lipids. Hepatic lipids are the important factor 
for insulin resistance and decreased insulin secretion [6]. Type-2 DM 
leads to gradual changes in glucose homeostasis. Insulin acts as the 
principal treatment for both the type of DM [7]. All the diabetic 
complication is caused by the oxidative stress mechanism [8]. Pre-
diabetes is a condition in which blood glucose levels are higher than 
normal but not high enough to be diagnosed as diabetes (i.e., Fasting 
blood glucose ≥100 mg/dl and ≤126 mg/dl) [3]. 
Diabetes in developing countries 
Regions with high potential to DM are Asia and Africa, where the 
rates could rise to 2-3 folds than the present rates [9]. The 
International Diabetes Federation (IDF) predicted that 40.9 million 
of Indian populations is affected by DM. This may increase to 69.9 
million by the year 2025 [10]. Diabetes is a major risk factor for 
cardiovascular disease, which is widely increasing in China [11]. 
Type-1 diabetes in low in Japan, compared to other populations in 
the world [12]. The diabetic population in various countries 
according to 2011 censuses is China-90 million, India-61.3 million, 
United States of America-23.7 million, Brazil-12.4 million, 
Bangladesh-8.4 million, Mexico-16.4million, Russia-14.1 million, 
Egypt-7.3 million and Indonesia-7.3 million. The expected diabetic 
population in 2030 is China-129.7 million, India-101.2 million, United 
States of America-29.6 million, Brazil-19.6 million, Bangladesh-16.8 
million, Mexico-16.4 million, Russia-14.1 million, Egypt-12.4 million, 
Indonesia-11.8 million and Pakistan-11.4 million [13]. Diabetes is 
rapidly increasing at alarming rates. Compared to type-1 DM, there is 
an increase in the rate type-2 DM [14]. Obesity and overweight are the 
main complications of insulin resistance [15, 16].  
Reasons for onset of diabetes 
The factor for a cardiovascular and metabolic disorder is high caloric 
intake, physical inactivity, sedentary lifestyle, consumption of 
energy-rich diet, obesity, higher life span [16]. Adipose tissue is the 
major site for lipid storage, which plays an important part in normal 
metabolic homeostasis and in the formation of disease like type-2 
diabetes [17]. Factors like leptin tumor necrosis factor-α (TNF-α) 
and plasminogen activator inhibitor type-1 (PAI-1) are considered 
to be associated with the production of the pathophysiology of 
obesity [18, 19]. 
Mechanism 
In DM insulin stimulates glucose transporter in skeletal muscle and 
fat; it also suppresses hepatic glucose production. These 
mechanisms affect the β cells of the pancreas by producing sufficient 
amounts of insulin to balance peripheral insulin resistance [20]. DM 
is a major risk factor for cardiovascular disease. Recent evidence 
proves that diabetes is related to a vascular complication, which 
could be due to oxidative stress. Increased production of reactive 
oxygen species (ROS) is formed due to the coupling of oxidative 
stress [21]. This also results in imbalance production of the body, 
antioxidant defense system. Reduced EDR (Endothelium Dependent 
Relaxation) and enhanced receptor-mediated contractions are the 
vascular complication which is associated with DM [22]. Oxidative 
stress is formed by hyperglycemia which is due to increase 
mitochondrial production of the superoxide anion, non-enzymatic 
glycation of proteins and glucose antioxidant. Stress-sensitive 
signaling pathways are activated by oxidative stress [23]. 
Glucose homeostasis is maintained by two primary hormones 
namely, insulin and glucagon, which tightly control blood glucose 
concentrations following ingestion of a carbohydrate-rich meal. 
Starch molecules which are digested in the upper gastrointestinal 
tract are hydrolyzed into monosaccharide and later absorbed into 
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the blood stream through various glucose transporters (GLUT). 
GLUT-2 transports glucose into pancreatic β cells of the islets of 
Langerhans. Insulin is secreted by the oxidation of glucose through a 
mechanism of adenosine triphosphate (ATP)-sensitive potassium 
channels, membrane depolarization followed by voltage-dependent 
calcium influx and subsequent exocytosis of insulin granules [24].  
Insulin reduces blood glucose level by (i) translocation of GLUT-4 
vesicles to the plasma membrane; insulin enhances the uptake of 
glucose in peripheral tissues, (ii) helps utilization or storage of 
glucose in the liver and (iii) promoting lipogenesis and inhibiting 
lipolysis in (WAT) white adipose tissues [25]. When blood glucose 
concentration declines, glucagon is secreted from α-cells of 
pancreatic islets. 
Glucagon raises blood glucose level by (i) enhancing glucose 
production and releasing it in a liver and (ii) releasing Free Fatty 
Acids (FFAs) and increasing lipolysis from adipose tissue. This can 
affect glucose homeostasis by targeting glucose-regulating processes 
in the pancreas, liver, skeletal muscle or adipose tissue [26]. 
Diabetic complications 
At the early stage of DM, biomarkers of oxidative stress are elevated 
in the liver [27]. Diabetes could cause cataract at a younger age [28]. 
In the end stage of diabetes, patients will be influenced by diabetic 
nephropathy which is a worldwide renal disease. Diabetic 
nephropathy is a defect in the glomerular filtration rate; 
characterized by glomerular hyperfiltration, increase urinary 
albumin excretion, glomerular, tubular epithelial hypertrophy and 
mesangial expansion with the accumulation of Extracellular Matrix 
Proteins (EXM) and increased basement membrane thickness [29, 
30]. Initial treatment for early stage diabetic patients is to change 
the lifestyle [31]. 
Organs affected 
DM leads to defects in insulin production and release of insulin or 
even improper action of insulin in various organs. The lens of the 
eye is one of the highly affected body parts in DM. This is because 
the extracellular glucose diffuses into the lens and it cannot be 
controlled by insulin [32]. Diabetic hyperglycemia can cause 
aggravated ischemic brain damages [25]. Type-2 DM leads to 
cognitive impairment [33–35]. DM is a harmful disorder that can 
lead to atherosclerosis, renal, nervous system and ocular damages 
[36]. DM can also result in significant morbidity and mortality with 
micro and macrovascular complication [37]. 
Synthetic drug used clinically  
Several classes of approved oral anti-diabetic drugs are available for 
the treatment and management of DM. Demerits of most drugs are 
undesirable side effects, drug interaction, and cost. Currently, 
several researchers are involved in identifying novel targets that can 
improve disorders of DM. Thus, glucocorticoid (GCs) are the potent 
antagonists of insulin action and promoters of gluconeogenesis in 
the liver, leading to increasing in blood glucose concentration [38]. 
Insulin can be directly stimulated by oral hypoglycemic agents that 
are released in blood concentration [38]. Insulin can be directly 
stimulated by oral hypoglycemic agents that are released from β-
cells such as sulfonylurea-based drugs. However, this insulin 
secretion from islets is enough to overcome peripheral insulin 
resistance and normalize blood glucose level in type-2 patients [7]. 
The important classes of oral hypoglycemic drugs are 
thiazolidinediones (TZDs), biguanides, α-glucosidase inhibitor and 
sulphonyl ureas [39]. The TZDs are used commonly, but they cause 
undesirable side effects like weight gain, fluid retention and heart 
failure. The biguanide metformin is not a complete therapy on its 
own because it mainly acts in the liver rather than muscle and this 
does not cause weight gain [40]. Some recently approved drugs such 
as dipeptidyl peptidase-IV inhibitors, glucagon like peptide-1 
agonists and amylin analogs are also used in the treatment of 
diabetes [41]. One of the therapeutic approaches to decrease 
postprandial hyperglycemia is by absorption of glucose via 
inhibition of carbohydrate-hydrolyzing enzymes such as glucosidase 
in the intestine [42]. 
Complication 
The absence of controlling normal blood glucose levels is the main 
disadvantage of sulfonylurea-based drugs [43, 44]. Anti-diabetic 
drugs can lead to various toxicities which are due to the continuous 
use of long-term therapy. Moreover, the high cost of these drugs is 
another issue for the patients in developed and developing 
countries. Hence, to reduce the side effect now drug discovery is 
focusing on natural plant sources. Recent research involves in 
finding of new compounds with therapeutic properties from 
chemical and pharmacological studies of medicinal plants [45]. 
Need for natural remedies 
Natural products and their derivatives have been a successful source 
of bioactive molecules in medicines much before the discovery of 
modern therapeutics in the post-genomic era. Traditional medicine 
from natural products is being used in treating human diseases for 
many years, and it is considered effective and safe [46]. Flavonoids 
are one of the most studied natural products which are found 
predominantly in several comestible fruits as part of daily food 
consumption [47]. Most of the studies on herbal and natural 
products have reported for the better anti-diabetic effects with 
lower cost and fewer side effects than synthetic drugs. Most anti-
diabetic herbs can improve β-cell function and increase the 
secretion of insulin from the islets of Langerhans, which have high 
antioxidant power [48]. 
Consumption of fruits and vegetables can decrease the incidence of 
type-2 diabetes which is rich in polyphenol [49]. Plants contain 
biologically active substances such as hypoglycemic, hypolipidemic 
and antioxidant agents, which play an important role in the 
discovery of new therapeutic [50]. India is composed of about 
45,000 plant species, and most of them have medicinal properties. 
Out of them, many herbal drugs reported having anti-diabetic 
activity in the Ayurvedic medicine of India [51].  
Flavonoids are capable of interacting with more than one target. The 
flavonoids or bioflavonoids are consisting of about 4000 compounds 
that occur in both flowering and non-flowering plants [52]. Recent 
investigations prove the anti-diabetic properties of flavonoids. In 
type-2 diabetes flavonoids can act against the progression of insulin 
resistance by reducing oxidative stress-induced tissue damage 
which therefore preserves the function of β-cells [53]. It is a part of the 
human diet which contains various properties including antioxidant, 
anti-inflammatory, antibacterial, anti-tumor, anti-allergic and anti-
mutagenic properties [54, 55]. It is also proved to have beneficial 
effects in cardiovascular disease by overproduction of reactive oxygen 
species [56]. Flavonoids are also described as glucosidase inhibitors. 
Glucosidase inhibitors are the active agents for diabetes therapy [57]. 
Flavones have the presence of hydroxyl groups, especially in C-30, C-
40 and C-7, and also the double bond between C-2 and C-3, which 
could increase the anti-diabetic activity [47]. 
Flavonoids represent a large class of at least 6,000 phenolic 
compounds found in fruits, vegetables, herbs, cocoa, chocolate, tea, 
soy, red wine and other plant food and beverage products. Structurally 
flavonoids consist of two aromatic rings (A and B chain) which are 
linked by 3 carbon chains that form an oxygenated heterocyclic ring (C 
ring) [58]. Flavonoids are bioactive phenols with low molecular weight 
and play a major role in cell synthesis [59]. Medicinal plants are widely 
used by the population of developing countries as an alternative 
therapy. In India, hundreds of plants are used traditionally for the 
management of DM. Unfortunately, only a few of such Indian medicinal 
plants have received scientific scrutiny [60]. 
Common Indian medicinal plants and their metabolites with 
antidiabetic activity 
In recent years, researchers are focusing on polyphenolic 
compounds, due to their beneficial properties in cardiovascular 
disease. Polyphenolic compounds have pharmacological effects such 
as anti-inflammatory, antioxidant, antiviral and anticarcinogenic 
agents [47]. Quercetin is widely found flavonoid in the human diet 
[56]. Quercetin helps in glucose absorption, which is investigated 
and proved by National Institutes of Health Clinical Center [47]. 
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Polygonatum odoratum consist of a dried rhizome which is called as 
Rhizoma Polygonatti odorati. This is highly cultivated in the southern 
area of china, which is known as Yu Zhu. It is a well-known herbal 
medicine among the Chinese which is commonly used for promoting 
secretion of fluid, removing dryness and quenching thirst in Chine. This 
is traditionally used as the treatment for DM. As a treatment for DM, it is 
administered orally as a single herb or with other medicinal plants after 
decoction in water. It is also cooked along with meats or porridges as 
health foods, which is widely practiced in southern China [61].  
Drug discovery is focusing on ‘new anti-diabetic drugs’ with a lower 
price and higher safety and efficacy, which could be a novel 
treatment for DM by the combination of antioxidant compounds [48, 
62]. Recently, it has been reported that the activity of glucose–
induced insulin release from pancreatic β-cells by anthocyanidins 
and anthocyanins. The dimethoxy ether and the glycoside of 
leucopelargonidin are obtained from the bark of the Indian banyan 
tree. Ficus bengalenis is possessed significant hypolipidemic, 
hypoglycemic and serum insulin-raising effects in moderate diabetic 
rats with close similarities to the effects of glibenclamide [49]. 
Fasting blood glucose levels can be reduced by TFP (Polygona 
tumodratum). This can also prevent and reduce hyperglycemia in 
alloxan and high-fat-diet-induced type-2 diabetic rats [61]. Several 
experimental trials prove that the consumption of flavonoid-rich 
foods such as tea and onion can increase the plasma levels in the 
diabetic patient. A study from Finland has recently demonstrated 
that the intakes of flavonoids like quercetin and myricetin are 
inversely associated with risk of type-2 DM [63]. 
Medicinal plants 
We have listed few medicinal plants used traditionally in Indian 
Ayurvedic medicine for the treatment and management of DM. The 
selection criteria include (i) use in Indian Ayurvedic medicine (ii) 
ethnopharmacological significance (iii) bioactive phytocompounds 
with antidiabetic potential and (iv) commercial availability. 
Eugenia jambolana 
Anthocyanins (ACs) are commonly found in various fruits, 
vegetables, flowers and grains and to some extent in leaves, stems, 
and roots. It belongs to a group of phenolic compounds. Eugenia 
jambolana is commonly known as Indian Blackberry or Jamun. 
Chemopreventive potential of ACs, anthocyanidins (ACdn) and 
polyphenolics are extracted from fruit pulp of this plant. The pulp of 
Jamun fruit consists of major ACs namely cyaniding 3,5-
diglucoside(Cy3,5), dolphin idin-3,5-diglucoside (Dp3,5), malvidin-
3,5-diglucoside (Mv3,5), petunidin-3,5-diglucoside (Pt3,5) and 
peonidin-3,5-diglucoside (Pe3,5). This plant is held against the 
treatment of cancer [64]. 
Syzgium alternifolium 
Syzgium alternifolium (SA) are locally termed as Mogi or 
Adavinerudu, which comes under the plant family Myrtaceae. 
Laboratory study has reported that seeds of SA have the activity of 
anti-hyperglycemic. Fever and skin related disease can be treated by 
SA. Aqueous extract of SA seeds can cure alloxan-induced diabetic 
rats at the dosage of 750 mg/kg b. w, which possesses anti-
hyperglycemic activity. Maximum activity of anti-hyperglycemic (83 
%) could be produced from the aqueous extract of SA seeds. Drugs 
from the extracted seeds can normalize the function of DM without 
causing hypoglycemia. Its activity is observed even from the first hour 
of treatment. The anti-hyperglycemic activity could form even at a 
lower dose (50 mg/kg b. w,) than the aqueous extract of other 
fractions and glibenclamide. During treatment, no hypoglycemic 
condition was observed in the treated diabetic rats [65]. 
Curcuma longa 
Curcuma longa has the activity like antibacterial, hypolipidemic, 
anti-diabetic, anti-inflammatory, antioxidant and anticancer. 
Quercetin is reported to possess the property like reduction of blood 
glucose, promotion of Langerhans islets regeneration and increasing 
insulin release which demonstrated its antidiabetic activity both in 
vitro and in vivo. The C. longa consists of an active ingredient like 
diferuloylmethane or 1, 6-heptadiene-3, 5-dione-1, 7-bis (4-
hydroxy-3-methoxyphenyl). In India and China, C. longa is used as a 
traditional medicine over a long period [48]. 
Aloe vera 
The extracted gel from Aloe vera is most commonly used as 
healthcare product [48]. It is also reported having beneficial 
therapeutic effects of DM [66]. A. vera gel consists of active 
ingredients like minerals, amino acids, polyphenols, and 
polysaccharides. The major polysaccharides in A. vera are glucose 
and mannose [67]. A. vera has been reported to possess the 
hypoglycemic effects [66]. Anti-diabetic activity of A. vera is 
observed by oral administration of its juice in a tablespoon twice a 
day for at least 2 w. The continuous administration of A. vera juice is 
reported to reduce the blood sugar and triglyceride level, but 
cholesterol levels are not affected. The results prove the potential 
use of A. vera juice as an anti-diabetic agent [68].  
Hibiscus sabdariffa 
The genus Hibiscus (Malvaceae) includes more than 300 species of 
perennial or annual herbs, shrubs or tree. Hibiscus sabdariffa L. (Hs) 
are found in tropical and subtropical zones of both hemispheres. 
They composed of three types namely red, dark red and green which 
are grown for its fibers and calyces. The commonly used type is red 
calyces. Extract of Hibiscus inhibits the activity of α-amylase, 
blocking sugars and starch absorption, which helps to reduce 
weight; this has been demonstrated by in vitro and in vivo studies 
[69]. Study on Hs has reported the anti-spermatogenic, androgenic, 
anti-tumor and anticonvulsant activities of the flowers. Heart 
disorders can also be treated by this flower. Anti-diabetic activity 
among DM in rural population is also reported in Hibiscus 
rosasinensis [70]. 
In India, Africa and Mexico, the leaves of Hs are used traditionally for 
their diuretic, choleretic, febrifugal and hypotensive effects. In China 
the seeds of Hs are used for making oil and the plant is invoked as 
traditional medicine. In Egypt, cardiac and nerve disease is treated 
by the leaves of Hs. This can enhance the production of urine 
(diuresis) and help in lowering the body temperature. Powdered 
leaves and seeds are used in meals, which are widely practiced in 
West Africa. It is also used in pharmaceutical and food industries. In 
North Africa, abscesses and external wounds are treated by the leaf 
pulp and the calyces are used as the treatment of sore throats and 
coughs, as well as genital problems. This also helps in decreasing the 
viscosity of the blood and stimulating intestinal peristalsis. In 
Senegal, it is employed to hypotensive. It is utilized to relieve pain in 
indigestion and urination. The roots are believed to have emollient 
and stomachic properties, in Brazil. In the folk medicine of China, 
high blood pressure and liver disorders are treated by Hs plant 
extract. In Nigeria, the decoration of the seeds is traditionally used 
for the poor letdown, maternal mortality and to increase or induce 
lactation in cases of inadequate milk production. Sour hibiscus tea is 
reported as a traditional treatment for hypertension in Iran [69]. 
Polyphenol extract of Hs was studied in type-2 diabetic rat models 
which prove its protective effects. It reduces hyperinsulinemia and 
hyperglycemia at the dosage of 200 mg/kg b.w., which 
demonstrated its anti-insulin properties. It contributes to reducing 
serum triacylglycerol, cholesterol and the ratio of low-density 
lipoprotein (LDL) and high-density lipoprotein (HDL). It also 
decreases plasma advanced glycation end products formation and 
lipid peroxidation [69]. 
Bacopa monnieri 
Bacopa monnieri is used along with a kudzu relieving hangover, 
fever and flu. It also improves liver function, enhancing the 
detoxification process, regulating cardiac functions and aiding 
weight loss [71]. This plant is reported to manage DM [72]. 
Embilica officinalis 
Embilica officinalis lies in the family Euphorbiaceae. In traditional 
Indian medicine, all the parts of plants, including fruits, seed, leaves, 
root, bark and flower are used for various herbal preparations. 
Leaves of E. officinalis is has been used for antipyretic and anti-
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inflammatory treatments. A study on the antioxidant potential and 
hypoglycemic effects of E. officinalis is reported producing anti-
diabetic action against streptozotocin-induced diabetic rats. This on 
continuing treatment for a period of 45 d produces a significant 
decrease in blood levels in diabetic rats, which is comparable to that 
of standard and diabetic control group. E. officinalis leaves are 
proved to be used as an natural alternative remedy for the treatment 
of diabetes [73]. In Ayurveda medicine, E. officinalis is used to 
promote health and longevity by increasing defense against disease 
[54, 62]. E. officinalis consist of vitamin C, which is used as 
scavenging free radicals [49]. E. officinalis is reported reducing the 
fasting serum glucose level compared to the baseline level. This also 
improves oral glucose tolerance in type-2 diabetic rats, but it does 
not change the total cholesterol level. E. officinalis is proved to have 
anti-diabetic and antioxidant properties on treatment for type-2 
diabetic rats and has not formed any toxic effect [74]. 
Momordica charantia 
Momordica charantia belongs to the family Cucurbitaceae, which is 
commonly known as kugua, karela, bitter gaurd or bitter melon. It is 
a tropical plant known to have hypoglycemic which could be used 
for diabetic studies in herbal medicine [54]. It can be utilized to treat 
infections like antiviral, antibacterial and anthelmintic [62]. It has 
anti-fertility effects on male animals [56, 75]. Cucurbitaceae (M. 
charantia L) is used as a traditional medicine by the Chinese people. 
Pharmacological studies have possessed its anti-diabetic, anti-tumor 
and antiviral activities. The crude extract of M. charantia has the 
property of lowering the blood glucose levels. The active ingredients 
of M. charanti are called as triterpenoids, which has reported 
showing anti-diabetic activity [76]. 
Anona squamosa 
Anona squamosa belongs to a family Annonaceae. It has the 
properties of insecticide, anti-ovulatory and abortifacient. This is 
generally used as an alternative therapy in many countries. In Brazil, 
the extract of A. squamosa seed is used to promote abortion [77].  
Bauhinia forficate 
Bauhinia forficate (Brazilian Orchid tree) is a type of evergreen tree, 
which is commonly used as a medicine for DM. Phytochemicals 
experiments helped to isolate a compound from B. forficate roots, bark 
and stems, which could be used against DM. Kaempferol and quercetin 
O-glycosides, are the compounds which are separated from this tree. 
Currently, drug discovery is going on in the leaf extract of kaempferitrin 
to find a novel drug for DM [78]. In Brazil, this is used as an herbal drug 
for the treatment of diabetes where it is known as “cow hoof” [52]. 
Allium sativum 
The common name of Allium sativum is garlic, which has been used 
as a medicinal plant since ancient times. They are highly cultivated 
in Iran. Garlic is used for the therapeutic purpose in the form of 
garlic oil garlic powder and pills. This is reported to lower the blood 
pressure and helps in improving lipid profile [79]. 
Centaurea cyanus 
It is a common class of phenolic compounds, which consist of 8000 
flavonoids and 500 anthocyanins. This has the protective effects like 
antioxidant, anti-allergic, anti-diabetic, anti-inflammatory, antiviral, 
anti-proliferative, anti-mutagenic, anti-microbial, anti-carcinogenic, 
microcirculation improvement, protection from cardiovascular 
damage, allergy protection, peripheral capillary fragility prevention 
and vision improvement [49]. 
Morus alba 
The leaves and root bark of the white mulberry tree (Morus alba L.) is 
said to be the source of phytotherapeutics. They are typically used for 
the treatment of type-2 diabetes. Antidiabetic activity of mulberry 
extract is proved by in vivo animals and human studies [80]. 
Averrhoa carambola 
In Brazil, Averrhoa carambola is used as the generic medicine to 
balance glucose levels [81]. 
Trigonella foenum 
Trigonella foenum is an annual herb, which belongs to the family 
Leguminosae; this grows abundantly in the Mediterranean region. 
Fenugreek seeds are employed in traditional Indian and Chinese 
medicine as a treatment for gastric disorders. Pharmacological 
studies have proved it properties like anti-diabetic, anti-
inflammatory, antibacterial hypocholesterolemic effects, 
hypolipidemic and neuroprotective potential. Seeds of T. foenum 
consist of secondary metabolites namely: polysaccharides, 
flavonoids, steroidal saponins and alkaloids [82–88]. Its seed is 
traditionally used in the treatment of type-2 DM in India, Egypt, Asia, 
Southern Europe and North Africa. Their seeds are certified as a 
generally recognized as safe (GRAS) by the US Food and Drug 
Administration (US FDA). The seeds are traditionally reported 
regulating hormones in the male. In India, extracts of this seed along 
with jaggery is given to females after the childbirth, which enhances 
the muscle strength. Their seed is reported to form lean body mass 
and helps in lowering cholesterol [84–88]. T. foenum extract is used 
to reduce the fat content in the body [85]. Their seeds are 
considered to have rich steroidal compounds [89,90]. The extracted 
gum is reported to have prebiotic effects which are used in animal 
husbandry as nutritional supplements and as a stabilizer for food 
industry [84]. Egypt, the seeds are used for bread making, herbal tea 
and also eaten after germination [85]. Their seeds are considered as 
Ayurvedic medicine, Traditional Chinese, and Arabic medicine. Their 
seeds are used as a galactagogue which is a milk producing agent 
that helps the nursing mothers to increase breast milk. Experiments 
on animal models have reported that the seed of Trigonella foenum 
is known to reduce serum glucose and helps in improving the 
glucose tolerance [87]. 
Terminalia bellirica 
Terminalia bellirica has bio-actives which possess antibacterial, 
antiviral and anti-inflammatory properties. They are the popular 
Ayurvedic formulation. Some experimental studies on Triphala and 
T. bellirica are reported to reduce the LDL oxidation [91]. 
Murraya koenigii 
Murraya koenigiiis used as traditional Indian medicine and also in 
Ayurveda and Siddha system [92,93]. This belongs to the family 
Rutaceae, which is widely distributed in southern Asia [93, 94]. 
Leaves, bark and roots of this plant are used in the treatment of 
dyspepsia, dysentery, chronic fever, mental disorder, diarrhea, 
nausea, and diarrhea. The boiled leaves are recommended for the 
treatment of hiccups and hoarseness. Leaves are applied externally 
to treat eruptions [92]. The leaves of this plant which is termed as 
curry leaves have been used as herbs in South Indian food [94]. 
Leaves are used in the treatment of piles, vomiting, itching, fresh 
cuts, inflammation, dysentery, and dropsy. M. koenigii is reported 
forming hypolipidemic activity. It is also suggested for treating a 
mild form of diabetes. Their leaves are rich in pharmacological 
agents like carbazole, alkaloids, flavonoids, furan coumarins, 
terpenoid and tannins [95]. This is also used as an analgesic, 
anesthetic agent and to cure eczema, rheumatism, and dropsy. Juice 
of M. koenigii is used to relieve the pain in kidney. They are reported 
to have anti-oxidative, anti-tumor, anti-mutagenic and anti-
inflammatory properties [93, 96]. In Ayurvedic medicine, the extract 
of the plant is used for the treatment of hysteria, hypertension, 
cough, hepatitis, rheumatism, skin eruption and poisonous bites. 
People use its stem for cleaning the teeth which help in 
strengthening the gums. The extract of this leave is reported to 
improve the renal function [93]. 
Urtica pilulifera 
Urtica pilulifera belong to the family Urticaceae, which is found 
widely in Palestinian and Sinai areas. Leaves of U. pilulifera are used 
for making tea, which also traditionally used for blood purification 
and to maintain hemostatic. This plant is reported to have the 
properties like a diuretic, antiasthmatic, anti-inflammatory, 
hypoglycemic and hemostatic. The extract of this plant is used in 
treating the symptoms caused by lower urinary tract infection. U. 
pilulifera is reported to have non-toxic, mutagenic and embryogenic 
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effects. An experimental study on streptozotocin-induced type-2 
diabetic rats has possessed pancreatic oxidative stress and 
inflammation in high-fat diet [97]. U. diocia and U. urens are used in 
the treatment of hyperthyroidism, eczema, hemorrhoids, bronchitis, 
cancer and rheumatism. In folk medicine, U. urens is used as a 
traditional medicine in Turky [98].  
Urtica diocia 
Urtica diocia is used against DM, which is also proved through 
pharmacological screening [98]. U. diocia is used by ancient 
Egyptians as a relief for arthritis and lumbago. This plant is also used 
as a medicine for rheumatism and muscular paralysis. Leaf extract of 
this plant is considered to have the anti-inflammatory property. The 
juice of these leaves is known to decrease body weight and systolic 
blood pressure. The extract of this plant is reported to have 
antioxidant properties in rat [99]. This species is cultivated 
commercially for the pharmaceutical purpose [100]
Cichorium intybus 
. 
Cichorium intybus is widely grown in northwestern Europe. The 
roots of this plant are considered to have the rich source of dietary 
fiber inulin. In France and Japan, the roots are used for the 
preparation of coffee, as there is no caffeine in it. The inulin 
produced from it is a good replacement of dietary fat, which will 
help to reduce calorie intake [101,102]. 
Ocimum garatissimum 
Ocimum garatissimum is mainly originated from Africa. The extract 
of this plant is reported to have antioxidant [103] and anti-diabetic 
activity [104, 105]. A study on healthy and diabetic mice has 
possessed the hypoglycemic effect of O. garatissimum [104]. 
Other medicinal plants 
Acacia nilotica belongs to the family Leguminosae. This has been 
observed to possess antibacterial, antioxidant and antidiabetic 
properties. People use its branches as tooth stick for cleansing the 
teeth [106]. 
Ajuga bracteosa belongs to the family Amiaceae. This has the 
properties like anticancer, anti-malaria, antimicrobial, antidiabetic, 
antioxidant, diuretic and stimulant users. The dried parts of the 
plant are used for ulcer, colic and jaundice [107]. 
Bombax ceiba belongs to the family Malvaceae. The properties found 
in this plans are anti-microbial, antioxidant, anti-inflammatory, anti-
obesity and anti-diabetic. Buds of this flower are used as the 
treatment for digestive problems [108, 109]. 
Calotropis procera is under the family Asclepiadaceae. This has the 
properties like anticancer, antifeedant, anti-fertility, antimicrobial, 
antioxidant, anti-inflammatory, anti-diabetic and hemolytic uses. 
The leaves are warmed and tied over the wounds for quick healing. 
The latex of stem and leaves are used to remove worms from the 
teeth and to treat skin disease [110]. 
Carissa opacais are used as an antioxidant, antimicrobial, 
antidiabetic and antitumor agent. They belong to the family 
Apocynaceae. Hepatitis and jaundice can be treated by the 
extraction. Fruits are used as a digestive stimulant [103]. 
Cassia fistula belongs to the family Leguminosae. This has the 
properties like abortifacient, anti-allergenic, anti-diabetic, anti-
inflammatory, antioxidant, hypoglycemic and astringent. The pulp of 
the fruit is used against constipation. Leaves are used as fodder; 
dried branches are used as fuels, and the pulp of the fruits is also 
used to relieve constipation in cattle [111]. 
Cuscuta reflexa belongs to the family Convolvulaceae. The whole 
plant is used as antioxidant, antimicrobial, antidiabetic, analgesic, 
anti-fertility, anti-lice and anti-anemia. They are also used to treat 
skin disease [112].  
Clematis grata comes under the family Ranunculaceae. The extract of 
this plant is the rich source of antioxidant, antimicrobial, 
antidiabetic and expectorant agent. The leaves are chopped and 
smelled, which is the treatment of nausea [103, 113]. 
Cynodon dactylon belongs to the family Poaceae. They are the rich 
source of anti-diabetic, antioxidant, and immune modulator, diuretic 
and anti-emetic. Aerial parts are made as paste, and it is applied on 
skin infection, injuries and eczema [114]. 
Cyperus kyllingia are proved to have the anti-diabetic properties. 
The roots showed significant anti-diabetic activity on oral 
administration of 750 mg/kg b.w. of cured root and 120 mg/kg b.w. 
of root extract [115]. 
Cyperus iria comes under the family Cyperaceae. They are used as 
antioxidant, antibacterial and Antidiabetic agent [103]. 
Cyperus rotundus belongs to the family Cyperaceae. They have 
properties like anti-diabetic, anti-diarrhoeal, cytoprotective, 
antimutagenic, antioxidant, anti-malaria, anti-inflammatory, 
antipyretic and analgesic agent. Stomach diseases can be cured by 
the rhizome of this plant [116]. 
Dicliptera roxburghianna comes under the family name Acanthaceae. 
They are reported to have the property of antioxidant, antimicrobial 
and anti-diabetic. Extract of the plant is used to avoid sun stroke in 
buffaloed [117, 118].  
Eruca sativa belongs to the family Brassicaceae. Activities observed 
from the extract of this plant are antitumor, antidiabetic, 
antihypertensive, antioxidant and antibacterial. Extract of this plant 
is used as a blood purifier, oil for cooking, massage and remove 
dandruff in hair [119,120]. 
Flacourtia indica comes under the family Flacourtiaceae. They are 
used as antioxidant, antimicrobial and anti-diabetic agents. Fruits of 
this plant are used against diabetes [121]. 
Fumaria indica belong to the family Fumariaceae. The properties 
found in this plant are antioxidant, antimicrobial, antidiabetic and 
analgesic [122–125]. 
Gallium aparine has the family name of Rubiaceae. This has the 
properties like antioxidant, antimicrobial and anti-diabetic. Their 
leaves are used in the treatment of jaundice. A paste of the leaves is 
used as the antiseptic which is externally applied on wounds [125]. 
Hedera nepalensis belongs to the family Araliaceae. The various 
properties found in this species are antipyretic and anti-diabetic. 
Juice from the leaves is used as anti-diabetic agent [126]. 
Ipomoea purpurea comes in the family name of Convolvulaceae. 
They are used as the antimicrobial, antioxidant and antidiabetic 
agent. They are used in the treatment of bronchitis [103]. 
Linum usitatissimum comes under the family name Linaceae. They 
consist of various properties like antimicrobial, antioxidant, 
antidiabetic, anti-hyperlipidemic, antioxidant, antidiabetic, anti-
arthritic, anti-asthmatic, anti-allergic, anti-inflammatory and also 
used for heart disease [127]. 
Mallotus philippensis belongs to the family Euphorbiaceae. Anti-
diabetic, antioxidant, are antimicrobial are the properties that are 
found in this plant. The crushed fruits are used orally to treat bloody 
diarrhea [128, 129]. 
Malvastrum coromandelianum comes under the family name of 
Malvaceae. This has properties like anti-diabetic, antioxidant and 
antimicrobial. Crushed leaves are used to treat DM. Seeds are used 
for curing leprosy [104]. 
Mentha longifolia belong to the family Lamiaceae. The various uses 
of this plant are anti-diabetic, antioxidant and anti-microbial 
activities. This herb is used in treating cholera and digestive 
problems [103]. 
Prunella vulgaris belongs to the family Lamiace. The various 
properties of this plant are antioxidant, antiviral, 
immunomodulatory, proliferative and anti-diabetic. The seeds can 
be used in the treatment of antipyretic, laxative and diuretic. This 
helps in treating inflammation, disease of the heart, difficulty in 
breathing and weakness of eyesight. This is also useful in curing 
fever and cough [130]. 
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The rate of diabetes is increasing due to changing food habits and 
increased uses of synthetic food products. Therefore, a reversion to 
increased usage of naturally obtained food products and food 
supplements would increase the resistance of the population to both 
diabetes incidence and diabetic complications.  
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